Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.83 USD | -3.68% | 0.00% | -23.43% |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Capitalization 1 | 306.5 | 248.6 | 90.33 | 75.85 | - | - |
Enterprise Value (EV) 1 | 306.5 | 191.6 | 65.83 | 10.76 | -29.79 | -59.74 |
P/E ratio | -5.18 x | -3.14 x | -1.3 x | -1.09 x | -1.18 x | -1.19 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | - | - |
EV / Revenue | - | - | - | - | - | - |
EV / EBITDA | - | -2.83 x | - | -0.16 x | 0.43 x | 0.74 x |
EV / FCF | - | -3.34 x | -1.09 x | -0.47 x | 1.75 x | 3.51 x |
FCF Yield | - | -29.9% | -91.6% | -214% | 57.1% | 28.5% |
Price to Book | - | 1.23 x | 0.91 x | 0.77 x | 0.81 x | 0.87 x |
Nbr of stocks (in thousands) | 32,130 | 37,838 | 37,794 | 41,448 | - | - |
Reference price 2 | 9.540 | 6.570 | 2.390 | 1.830 | 1.830 | 1.830 |
Announcement Date | 3/15/22 | 3/6/23 | 3/12/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - |
EBITDA 1 | - | - | -67.72 | - | -68.03 | -69.73 | -80.97 |
EBIT 1 | - | -45.65 | -67.88 | -78.93 | -61.12 | -68.81 | -102.1 |
Operating Margin | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | - | -45.51 | -65.58 | -72.52 | -76.95 | -84.6 | -96.25 |
Net income 1 | -26.45 | -47.01 | -66.65 | -74.56 | -72.12 | -68.68 | -89.44 |
Net margin | - | - | - | - | - | - | - |
EPS 2 | -9.950 | -1.840 | -2.090 | -1.840 | -1.683 | -1.551 | -1.539 |
Free Cash Flow 1 | - | - | -57.34 | -60.28 | -23 | -17 | -17 |
FCF margin | - | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 7/22/21 | 3/15/22 | 3/6/23 | 3/12/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA 1 | - | - | - | - | - | -17.05 | - | -20.04 | -19.33 | - | -19.79 | -17 | -16 | -16 | - |
EBIT 1 | -9.981 | -12.31 | -14.32 | -17.62 | -18.86 | -17.09 | -18.37 | -20.08 | -19.36 | -21.11 | -19.79 | -15.62 | -13.78 | -14.05 | -11.7 |
Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -9.864 | -12.19 | -14.11 | -17.24 | -18.24 | -15.99 | -16.76 | -18.41 | -17.73 | -19.63 | -18.34 | -20.5 | -20.1 | -20.3 | - |
Net income 1 | -10.2 | -12.42 | -14.5 | -17.58 | -18.37 | -16.2 | -17.32 | -18.63 | -18.37 | -20.24 | -19.03 | -19.58 | -18.2 | -17.05 | - |
Net margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EPS 2 | -0.3700 | -0.4200 | -0.4800 | -0.5700 | -0.6000 | -0.4600 | -0.4300 | -0.4600 | -0.4500 | -0.5000 | -0.4700 | -0.4033 | -0.3567 | -0.2800 | -0.3100 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 11/10/21 | 3/15/22 | 5/10/22 | 8/8/22 | 11/7/22 | 3/6/23 | 5/9/23 | 8/8/23 | 11/9/23 | 3/12/24 | 5/9/24 | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - | - |
Net Cash position 1 | - | - | 57 | 24.5 | 65.1 | 106 | 136 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
Free Cash Flow 1 | - | - | -57.3 | -60.3 | -23 | -17 | -17 |
ROE (net income / shareholders' equity) | - | - | -38.6% | -52.6% | -51.6% | -40.3% | -38.8% |
ROA (Net income/ Total Assets) | - | - | -36.8% | -49% | -47.6% | -37.6% | -36.7% |
Assets 1 | - | - | 181.3 | 152.2 | 151.4 | 182.6 | 244 |
Book Value Per Share 2 | - | - | 5.320 | 2.630 | 2.370 | 2.270 | 2.090 |
Cash Flow per Share | - | - | - | - | - | - | - |
Capex | - | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - | - |
Announcement Date | 7/22/21 | 3/15/22 | 3/6/23 | 3/12/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.43% | 75.85M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- RLYB Stock
- Financials Rallybio Corporation